From rare diseases to chronic conditions, epigenetic editing unlocks new ways to control gene activity without altering the genetic code.
The global market is estimated at USD 25,900.5 million in 2025 and is forecast to reach USD 64,187.5 million by 2035, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback